Abstract: An identity management system detects the occurrence of a trigger event, such as a time period expiration, or an action on the identity management system. The identity management system accordingly generates a new password for an account of a user on a third-party service and causes the account of the user on the third-party service to use the new password. The identity management system can also detect a manual user change of a password for a third-party service and cause configuration of client devices of the user to reflect the new password.

Abstract: An improved approach is provided for determining differential voltages for driver and receiver pairs as a result of electrostatic discharge (ESD) events including identifying circuits of interest, re-characterizing the circuits of interest into a system for evaluating differential voltages, determining the differential voltages for ESD pin locations, and outputting results after iterating through all the ESD pin locations. In some embodiments, re-characterizing may include performing a resistance only extraction of a net, attaching a resistance to any node in the circuit and to ground, formulating a conductance matrix and distributing the total current I as source points.

Abstract: A display panel, a display method thereof and a display device are disclosed. The display panel includes an electrochromic layer (101) and an electrolyte layer (102) arranged in a stacked manner, and at least one kind of colored charged particles (103) being provided in the electrolyte layer (102). While the electrochromic layer (102) is transparent, the display panel displays color of the colored charged particles (103). The display panel may further display the color of the colored charged particles, which increases diversity of the colors displayed by the display panel.

Abstract: An electrical connector includes an terminal module and a metallic tubular shield fixedly enclosing the terminal module to form a sub-assembly, and a metallic tubular bracket enclosing the sub-assembly. The terminal module includes an insulator having a base and a tongue portion forwardly extending from the base, and a plurality of terminals disposed in the insulator. The base includes a rear end having a securing section, and the bracket has a fixing section correspondingly, wherein the bracket is adapted to be forwardly assembled from a rear side of the sub-assembly to have the fixing section engaged with the securing section.

Abstract: An identity management system detects the occurrence of a trigger event, such as a time period expiration, or an action on the identity management system. The identity management system accordingly generates a new password for an account of a user on a third-party service and causes the account of the user on the third-party service to use the new password. The identity management system may also a mobile device management system to configure a client of the user with the new password.

Abstract: The present invention provides compounds of Formula I and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.

Abstract: Novel spirocyclic compounds of formula I: and pharmaceutically acceptable salts thereof are disclosed as inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention. Pharmaceutical compositions and methods of treatment are also included.

Abstract: The present application discloses a method for fabricating a display substrate including forming an electrode layer comprising a plurality of electrode blocks on a base substrate; each electrode block corresponding to a subpixel region; and forming an electrochromic layer comprising a plurality of electrochromic blocks on the electrode layer by electrochemically depositing an electrochromic material onto the plurality of electrode blocks on a side of the electrode layer distal to the base substrate, each electrochromic block corresponding to each electrode block in a one-to-one relationship.

Abstract: An array substrate, an electrochromic display and a method for driving the array substrate are disclosed. A display region of the array substrate (30) comprises a plurality of sets of data lines (33) and a plurality of scan lines (36), the plurality of sets of data lines (33) and the plurality of scan lines (36) intersecting each other to divide the display region into a plurality of pixel regions, a pixel electrode (32) is disposed in each of the pixel regions and electrically connected to the data lines (33); the pixel electrode (32) comprises a central pixel electrode (32a) and a peripheral pixel electrode (32b) adjacent to and electrically isolated from the central pixel electrode (32a).

Abstract: The present invention provides compounds of Formula I and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.

Abstract: The present invention provides compounds of Formula I and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.

Abstract: An electrical connector with a terminal module enclosed within an insulative shield wherein the terminal module includes a plurality of terminals embedded within an insulative main body. The insulative main body forms a rear mounting standing part and a front mating tongue part extending forwardly from the rear mounting standing part. The insulative shield forms a rearward step against a forward shoulder of the base portion so as to prevent further forward movement of the base portion relative to the insulative shield. The insulative main body forms a protrusion and the insulative shield forms a securing hole to receive said protrusion for securing the insulative shield and the terminal module together.

Abstract: The present invention provides compounds of Formula I and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.

Abstract: Embodiments of the present invention disclose a double-faced display panel and a manufacturing method thereof, the double-faced display panel includes: an array substrate, including a first transparent substrate, a first trans-reflective layer formed on the first transparent substrate and a first electrode layer formed on the first trans-reflective layer; an opposed substrate, disposed to face the array substrate, and including a second transparent substrate, a second trans-reflective layer formed on a side of the second transparent substrate facing the first transparent substrate and a second electrode layer formed on a side of the second transparent substrate facing the first transparent substrate; a display structure, disposed between the array substrate and the opposed substrate and including a plurality groups of display units arranged in matrix, wherein each of the first and second trans-reflective layers includes a plurality of reflection regions and a plurality of transmission regions disposed alterna

Abstract: A capsule Quantum Dot (QD) composition, a light-emitting diode, preparation methods and a display apparatus are provided. The capsule QD composition includes a mesoporous material in submicron or micron order, quantum dots (QDs) adsorbed in pores of the mesoporous material, and an encapsulation material for packaging the QDs in the pores of the mesoporous material.

Abstract: A wire-grid polarizing element comprising a base substrate, and a carbon nanotube wire-grid and a metal wire-grid which are disposed on the base substrate, wherein the metal wire-grid and the carbon nanotube wire-grid are laminated in a direction perpendicular to the base substrate, and the carbon nanotube wire-grid comprises a plurality of carbon nanotubes having the same axial direction.

Abstract: A writing board, comprising: a first substrate and a second substrate opposed to each other, and liquid crystals filled between the first substrate and the second substrate, wherein the first substrate comprises a first electrode, the second substrate comprises a second electrode, the first electrode comprises a plurality of first sub-electrodes, and the first sub-electrodes are configured to accept touch control operations. An electronic writing device and a method for fabricating a writing board are also provided.

Abstract: The present invention provides compounds of Formula (I) and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.

Abstract: The present invention relates to compounds of formula (I) that are metallo-?-lactamase inhibitors, the synthesis of such compounds, and the use of such compounds for use with ?-lactam antibiotics for overcoming resistance.

Abstract: The present invention provides compounds of Formula I and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.